Biliary atresia is a rare and serious liver disease that affects infants. It is characterized by the absence or underdevelopment of the bile ducts, which are responsible for carrying bile from the liver to the gallbladder and small intestine. Without proper bile flow, the liver becomes damaged over time, leading to liver failure if left untreated.
The prevalence of biliary atresia varies across different populations and regions. Globally, it is estimated to affect approximately 1 in every 10,000 to 20,000 live births. However, the prevalence can be higher in certain ethnic groups or geographic areas. For example, in some Asian countries, the incidence of biliary atresia is reported to be as high as 1 in every 5,000 live births.
Early diagnosis and prompt surgical intervention are crucial for improving outcomes in infants with biliary atresia. The Kasai procedure, a surgical technique that creates an alternative pathway for bile drainage, is the primary treatment option. However, even with timely intervention, many children with biliary atresia may eventually require a liver transplant.
Biliary atresia is a rare liver disease that primarily affects infants, with a global prevalence of approximately 1 in every 10,000 to 20,000 live births. Early detection and appropriate medical intervention are essential for managing the condition and preventing long-term complications.